Mercer Capital Advisers Exits Position in Metlife Inc (MET)

Metlife Inc (MET) : Mercer Capital Advisers has sold out all of its stake in Metlife Inc during the most recent quarter, according to the disclosure filed by the company on Apr 21, 2016 with the SEC. The investment management company has sold out 825 shares of Metlife Inc which is valued at $38,693.

Metlife Inc opened for trading at $46.63 and hit $46.97 on the upside on Wednesday, eventually ending the session at $46.75, with a gain of 0.06% or 0.03 points. The heightened volatility saw the trading volume jump to 75,92,887 shares. Company has a market cap of $51,269 M.

Other Hedge Funds, Including , Sanders Capital boosted its stake in MET in the latest quarter, The investment management firm added 134,564 additional shares and now holds a total of 5,381,678 shares of Metlife Inc which is valued at $252,400,698. Metlife Inc makes up approx 2.08% of Sanders Capital’s portfolio.Osborn Rohs Williams Donohoe Ltd boosted its stake in MET in the latest quarter, The investment management firm added 300 additional shares and now holds a total of 5,253 shares of Metlife Inc which is valued at $234,546. Metlife Inc makes up approx 0.05% of Osborn Rohs Williams Donohoe Ltd’s portfolio.Lenox Wealth Advisors reduced its stake in MET by selling 65 shares or 36.11% in the most recent quarter. The Hedge Fund company now holds 115 shares of MET which is valued at $5,135.

On the company’s financial health, Metlife Inc reported $1.23 EPS for the quarter, missing the analyst consensus estimate by $ -0.13 based on the information available during the earnings call on Feb 3, 2016. Analyst had a consensus of $1.36. The company had revenue of $17111.00 million for the quarter, compared to analysts expectations of $17598.80 million. The company’s revenue was down -6.2 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.38 EPS.

Many Wall Street Analysts have commented on Metlife Inc. Company shares were Reiterated by UBS on Mar 15, 2016 to “Neutral”, Firm has raised the Price Target to $ 44 from a previous price target of $42 .Shares were Reiterated by Barclays on Feb 4, 2016 to “Overweight” and Lowered the Price Target to $ 53 from a previous price target of $60 .

MetLife Inc. (MetLife) is a provider of life insurance annuities employee benefits and asset management. The Company’s segments include Retail; Group Voluntary & Worksite Benefits and Corporate Benefit Funding. Its three geographic segments are Latin America (collectively the Americas); Asia and Europe the Middle East and Africa (EMEA). In addition MetLife’s Corporate & Other includes MetLife Home Loans LLC (MLHL) the surviving non-bank entity of the merger of MetLife Bank National Association (MetLife Bank) with and into MLHL and other business activities. Through its subsidiaries and affiliates it operates in the United States Japan Latin America Asia Europe and the Middle East. The Company‘s businesses in the Americas offer a range of protection products and services.

Leave a Reply

Metlife Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Metlife Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.